We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

193 hedge funds and large institutions have $571M invested in SANGAMO THERAPEUTICS INC in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 59 increasing their positions, 59 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more call options, than puts

Call options by funds: $7.57M | Put options by funds: $5.1M

7% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 28

1% more ownership

Funds ownership: 51.79% → 52.79% (+1%)

0% more funds holding

Funds holding: 193 → 193 (0)

0% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 59

16% less capital invested

Capital invested by funds: $679M → $571M (-$107M)

Holders
193
Holders Change
–
Holders Change %
0%
% of All Funds
2.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
59
Reduced
59
Closed
28
Calls
$7.57M
Puts
$5.1M
Net Calls
+$2.47M
Net Calls Change
+$276K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$9.59M
2
HighTower Advisors
HighTower Advisors
Illinois
+$7.94M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$4.45M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$4.14M
5
BlackRock
BlackRock
New York
+$3.24M

Top Sellers

Rank Fund Capital Flow
1
SG Americas Securities
SG Americas Securities
New York
-$5.47M
2
JP Morgan Chase
JP Morgan Chase
New York
-$3.77M
3
Goldman Sachs
Goldman Sachs
New York
-$3.71M
4
GIM
Granahan Investment Management
Massachusetts
-$3.14M
5
MIG
McGuire Investment Group
Rhode Island
-$2.06M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$4.16M +$4.45M +512,831 +1,224%
RCMU
27
Rokos Capital Management (UK)
United Kingdom
$4.11M – – –
Two Sigma Investments
28
Two Sigma Investments
New York
$3.63M +$402K +46,249 +11%
Federated Hermes
29
Federated Hermes
Pennsylvania
$3.63M +$4.14M +476,288 +5,966%
Mirae Asset Global Investments
30
Mirae Asset Global Investments
South Korea
$3.42M +$830K +95,599 +27%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$3.29M +$26.6K +3,058 +0.7%
Bank of America
32
Bank of America
North Carolina
$3.21M -$258K -29,669 -6%
UBS Group
33
UBS Group
Switzerland
$3.06M +$1.03M +118,557 +41%
Macquarie Group
34
Macquarie Group
Australia
$3.02M – – –
Rafferty Asset Management
35
Rafferty Asset Management
New York
$2.82M +$1.54M +177,395 +89%
Citigroup
36
Citigroup
New York
$2.73M +$1.16M +133,357 +58%
William Blair & Company
37
William Blair & Company
Illinois
$2.59M +$3M +344,902 New
Swiss National Bank
38
Swiss National Bank
Switzerland
$2.03M – – –
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$1.98M +$591K +67,980 +35%
LFCM
40
Long Focus Capital Management
Puerto Rico
$1.84M +$2.13M +245,000 New
Group One Trading
41
Group One Trading
Illinois
$1.8M -$55.5K -6,387 -3%
PIM
42
Platinum Investment Management
Australia
$1.64M – – –
AGA
43
Altrinsic Global Advisors
Connecticut
$1.62M – – –
Barclays
44
Barclays
United Kingdom
$1.39M +$624K +71,799 +64%
Ohio Public Employees Retirement System (OPERS)
45
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.33M – – –
BPC
46
Banque Pictet & Cie
Switzerland
$1.3M +$1.51M +173,832 New
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$1.26M +$43.2K +4,972 +3%
CSS
48
Cubist Systematic Strategies
Connecticut
$1.25M +$881K +101,404 +155%
Tudor Investment Corp
49
Tudor Investment Corp
Connecticut
$1.21M +$700K +80,559 +99%
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$1.16M – – –
1
2
3 4 5

SGMO Hedge Fund Activity: Q4 2021 in Review

193 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q4 2021, worth a combined $571M — down 16% from $679M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new SGMO positions and 28 closed out — a net gain of 2 holders — while 59 added to existing stakes and 59 trimmed.

The largest buyer was Millennium Management, adding an estimated $9.59M. The largest seller was SG Americas Securities, cutting an estimated $5.47M.

  • 193 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $571M of SANGAMO THERAPEUTICS INC stock for Q4 2021, down 16% quarter-over-quarter.
  • 30 funds opened new SANGAMO THERAPEUTICS INC positions in Q4 2021 and 28 closed out, a net change of +2 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q4 2021 was Millennium Management, an estimated $9.59M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q4 2021 was SG Americas Securities, an estimated $5.47M sold.

Based on aggregated 13F filings for Q4 2021.